Evaluation of different bone markers in hemodialyzed patients

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 107-111

  Cavalier, Etienne ^a   Delanaye, Pierre ^a   Collette, Julien ^a   Krzesinski, Jean Marie ^a   Chapelle, Jean Paul ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

25 OH vitamin D; Bone alkaline phosphatase; Hemodialyze; Homocystein; PTH

Indexed keywords

25 HYDROXYVITAMIN D; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; CALCITRIOL; CARBOXY TERMINAL TELOPEPTIDE; HOMOCYSTEINE; PARATHYROID HORMONE; PROCOLLAGEN N PROTEINASE; TARTRATE RESISTANT ACID PHOSPHATASE 5 B; UNCLASSIFIED DRUG;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; BONE TURNOVER; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL OSTEODYSTROPHY;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; FEMALE; HOMOCYSTEINE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; VITAMIN D;

EID: 33746742946     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.029     Document Type: Article

References (20)

1. Coen G., Ballanti P., Bonucci E., et al. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 13 (1998) 2294-2302
2. Rix M., Andreassen H., Eskildsen P., Langdahl B., and Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56 (1999) 1084-1093
3. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350 (2004) 2033-2041
4. Holmes D.T., Levin A., Forer B., and Rosenberg F. Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients. Clin Chem 51 (2005) 915-917
5. Salusky I.B., Ramirez J.A., Oppenheim W., Gales B., Segre G.V., and Goodman W.G. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45 (1994) 253-258
6. Reichel H., Esser A., Roth H.J., and Schmidt-Gayk H. Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18 (2003) 759-768
7. Slatopolsky E., Finch J., Clay P., et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 58 (2000) 753-761
8. Cavalier E., Delanaye P., Krzesinski J.M., and Chapelle J.P. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients. Clin Chem Lab Med 43 (2005) 890-891
9. Monier-Faugere M.C., Geng Z., Mawad H., et al. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60 (2001) 1460-1468
10. Coen G., Bonucci E., Ballanti P., et al. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40 (2002) 348-354
11. Salusky I.B., Goodman W.G., Kuizon B.D., et al. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63 (2003) 1801-1808
12. Sato Y., Honda Y., Iwamoto J., Kanoko T., and Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293 (2005) 1082-1088
13. Raisz L.G. Homocysteine and osteoporotic fractures-culprit or bystander?. N Engl J Med 350 (2004) 2089-2090
14. D'Amour P., Brossard J.H., Rousseau L., Roy L., Gao P., and Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 49 (2003) 2037-2044
15. Reichel H., and Schmidt-Gayk H. The role of 25-hydroxyvitamin D in normal and disturbed calcium metabolism. Eur J Clin Invest 33 (2003) 281-282
16. Bervoets A.R., Spasovski G.B., Behets G.J., et al. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis 41 (2003) 997-1007
17. Ueda M., Inaba M., Okuno S., et al. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77 (2005) 1130-1139
18. Ueda M., Inaba M., Okuno S., et al. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77 (2005) 1130-1139
19. Ueda M., Inaba M., Okuno S., et al. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 40 (2002) 802-809
20. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (2003) S1-S201